4//SEC Filing
Mitchell Stephen Ray 4
Accession 0000950170-25-087025
CIK 0001347178other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 9:10 PM ET
Size
5.0 KB
Accession
0000950170-25-087025
Insider Transaction Report
Form 4
Mitchell Stephen Ray
Director
Transactions
- Sale
Common Stock
2025-06-13$4.59/sh−7,000$32,130→ 97,082 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.58 to $4.605, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001802653
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 9:10 PM ET
- Size
- 5.0 KB